This inventor holds 1 USPTO granted patent. Top assignee: Step Pharma S.a.s.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of David Cousin
Introduction
David Cousin is an accomplished inventor known for his contributions to the field of pharmaceuticals. He has developed innovative compounds that have the potential to treat proliferative diseases. His work is characterized by a strong focus on human health and the development of effective therapies.
Latest Patents
David Cousin holds a patent for N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases. This patent highlights his expertise in creating novel compounds that target specific biological pathways.
Career Highlights
Throughout his career, David has made significant strides in pharmaceutical research and development. His work at Step Pharma S.a.s. has positioned him as a key player in the industry. He has demonstrated a commitment to advancing medical science through innovative solutions.
Collaborations
David has collaborated with notable colleagues, including Joseph William Wrigglesworth and Emma Blackham. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
David Cousin's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for advancements in the treatment of proliferative diseases.